AI is redefining decision-making in biopharma R&D
AI has kickstarted a new wave of innovation in biopharma R&D.
Newsletters and Deep Dive digital magazine
AI has kickstarted a new wave of innovation in biopharma R&D.
Bioptimus, a global AI biotech company, has announced a partnership with Cancer Research Horizons, the innovation engine of Cancer Research UK.
ARPA-H has awarded Siemens Healthineers up to $31.1 million over five years to accelerate the development of autonomous remote endovascular robotics.
New analysis from Tufts CSDD and Medable shows AI agent value to oncological drug development programmes at up to $21m each.
In an exclusive video interview, Steve Sanghera – CEO and co-founder of Inventus – sat down with pharmaphorum to discuss the company's journey & ethos
Editor's Picks
Newsletters and Deep Dive
digital magazine